AU5386700A - A use of icariin in preparing the medicine for preventing and treating sexual disorder and vasoconstrictive diseases - Google Patents

A use of icariin in preparing the medicine for preventing and treating sexual disorder and vasoconstrictive diseases

Info

Publication number
AU5386700A
AU5386700A AU53867/00A AU5386700A AU5386700A AU 5386700 A AU5386700 A AU 5386700A AU 53867/00 A AU53867/00 A AU 53867/00A AU 5386700 A AU5386700 A AU 5386700A AU 5386700 A AU5386700 A AU 5386700A
Authority
AU
Australia
Prior art keywords
icariin
medicine
preparing
preventing
sexual disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53867/00A
Other languages
English (en)
Inventor
Zhongcheng Xin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU5386700A publication Critical patent/AU5386700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296—Epimedium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU53867/00A 1999-06-17 2000-06-16 A use of icariin in preparing the medicine for preventing and treating sexual disorder and vasoconstrictive diseases Abandoned AU5386700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR9922665 1999-06-17
KR19990022665 1999-06-17
PCT/CN2000/000161 WO2000078323A1 (fr) 1999-06-17 2000-06-16 Utilisation de l'icariine dans la preparation de medicaments pour la prevention et le traitement de troubles de l'erection et de maladies vasoconstrictrices

Publications (1)

Publication Number Publication Date
AU5386700A true AU5386700A (en) 2001-01-09

Family

ID=19592994

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53867/00A Abandoned AU5386700A (en) 1999-06-17 2000-06-16 A use of icariin in preparing the medicine for preventing and treating sexual disorder and vasoconstrictive diseases

Country Status (5)

Country Link
JP (1) JP4864259B2 (zh)
KR (1) KR100394329B1 (zh)
CN (1) CN1199647C (zh)
AU (1) AU5386700A (zh)
WO (1) WO2000078323A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1199647C (zh) * 1999-06-17 2005-05-04 北京东方百奥医药开发有限公司 淫羊藿甙在制备用于预防或治疗勃起功能障碍的药物中用途
ITMI20020994A1 (it) * 2002-05-10 2003-11-10 Indena Spa Formulazioni utili nel trattamento dell'impotenza maschile e femminile
ITMI20031427A1 (it) * 2003-07-11 2005-01-12 Indena Spa Combinazioni di agenti vasoattivi, loro uso in campo farmaceutico e cosmetico e formulazioni che li contengono
KR100821683B1 (ko) * 2006-11-01 2008-04-15 우석대학교 산학협력단 이카리사이드 Ⅱ (ｉｃａｒｉｓｉｄｅ Ⅱ)를 유효성분으로 하는 혈관 형성 장애 관련 질환의 예방 및 치료용 조성물
WO2009066712A1 (ja) * 2007-11-21 2009-05-28 Kracie Pharma, Ltd. アロマターゼ阻害剤
US8530433B2 (en) 2008-06-13 2013-09-10 Bjo-Biomed Ltd Use of icariside II in manufacture of products for preventing or treating male or female sexual dysfunction
KR101019340B1 (ko) 2008-07-07 2011-03-07 전북대학교산학협력단 복분자 효능 확인 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000319191A (ja) * 1999-03-05 2000-11-21 Takeda Chem Ind Ltd サイクリックｇｍｐ特異的ホスホジエステラーゼ阻害剤および性的機能障害改善薬
CN1199647C (zh) * 1999-06-17 2005-05-04 北京东方百奥医药开发有限公司 淫羊藿甙在制备用于预防或治疗勃起功能障碍的药物中用途

Also Published As

Publication number Publication date
JP4864259B2 (ja) 2012-02-01
WO2000078323A1 (fr) 2000-12-28
KR20010029802A (ko) 2001-04-16
CN1199647C (zh) 2005-05-04
JP2003502376A (ja) 2003-01-21
CN1282584A (zh) 2001-02-07
KR100394329B1 (ko) 2003-08-09

Similar Documents

Publication Publication Date Title
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
IL174732A0 (en) Use of crystal modification of a n-phenyl-2-pyrimidineamine derivative in the preparation of a medicament for the treatment of restenosis
AU1063201A (en) Use of tgf beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa
AU2002246152A1 (en) Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases
IL187512A0 (en) Use of (s,s)-reboxetine in the treatment of pain conditions and incontinence
AU1227302A (en) System and method for optimizing drug therapy for the treatment of diseases
AU1200501A (en) Drug delivery catheters that attach to tissue and methods for their use
AU2001275177A1 (en) Cardiac disease treatment and device
AU2001275176A1 (en) Cardiac disease treatment and device
AU2001253565A1 (en) Cardiac disease treatment and device
AU7186501A (en) Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
AU2001281369A1 (en) Cardiac disease treatment and device
AU2598300A (en) A device for therapeutic treatment of the temporomandibular and maxillomandibular region and method for using same
AU2072201A (en) Agents and methods for the treatment of proliferative diseases
IL144730A (en) Use of statin drug in the preparation of a medicament and as a medicament for the treatment of diabetic neuropathy
EP1139746A4 (en) CONNECTIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY DISEASES AND THE ADMINISTRATION OF MEDICINAL SUBSTANCES
HUP0104803A3 (en) Process and system for the administration of medicine through the skin
HK1040055A1 (en) Use of olanzapine and fluoxetine in the preparation of a medicament for the treatment of treatment resistant major depression.
AU1164601A (en) Therapeutic use and formulation
HK1022269A1 (en) Use of 1-hydroxy-2-pyridones in the manufacture of a medicament for treating skin infections
PL321779A1 (en) Drug for use in therapy of obsessive-compulsive neurosis, sleep apnoea, secsual activity disorders, vomiting and kinetosis
AU5386700A (en) A use of icariin in preparing the medicine for preventing and treating sexual disorder and vasoconstrictive diseases
HUP0203468A3 (en) Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof
AU6126498A (en) Method for the treatment of drug addiction and homeopathic remedy
AU7965000A (en) Use of analgesics as digestive and medicines for expectorating and transdermal therapeutic system using the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase